Here’s why Agios Pharmaceuticals stock rose today
The new indication is relatively rare in the US, but the price is substantial and the need for treatment is significant. The positive update turns the company’s fortunes around after a disappointing update earlier in the year. 10 stocks we like better than Agios Pharmaceuticals › Actions in Agios Pharmaceuticals (NASDAQ: AGIO) it shot up…